Pathos AI logo

Pathos AI

Challenger

Clinical-stage AI company raised $365M Series D at $1.6B for world's largest multimodal oncology AI; Novo Nordisk partnership; $467M total;

Best for: AI Oncology
52
AI Score
Grade C
AI Visibility Score (Beta)
HealthcareAI OncologyWebsiteUpdated November 2026

Brand Intelligence Graph

Powered byGoogle
Capabilities
AI Oncology

Company Overview

About Pathos AI

Pathos AI is a clinical-stage AI company building the world's largest multimodal oncology AI platform, combining pathology imaging, genomics, clinical records, and treatment outcome data to power precision cancer care. Founded by oncologists, pathologists, and AI researchers, Pathos has assembled a dataset at a scale that gives its models a meaningful edge: by ingesting vast quantities of multimodal cancer data, its platform can predict treatment responses, identify biomarkers, and guide therapy selection with a level of accuracy that single-modality systems cannot match.

Business Model & Competitive Advantage

The platform serves oncologists and cancer centers by providing AI-augmented pathology reads, treatment outcome predictions, and clinical trial matching. Pathos's AI can analyze whole-slide pathology images in combination with molecular and clinical data to generate insights that inform diagnosis and treatment decisions. The company has also built partnerships with pharmaceutical companies — including Novo Nordisk and Prelude Therapeutics — to use its platform for drug development and clinical trial design, adding a biopharma revenue stream alongside its clinical business.

Competitive Landscape 2025–2026

Pathos raised $365M in a Series D round at a $1.6B valuation, bringing total funding to $467M. The Series D was one of the largest oncology AI fundraises in history and included backing from top-tier life sciences investors. The Novo Nordisk and Prelude partnerships validate the platform's scientific depth and its utility across both clinical care and drug development. As of 2025–2026, Pathos is advancing toward direct clinical deployment and regulatory submissions, positioning itself as a core infrastructure layer for the future of AI-guided cancer treatment.

Curated content • Fact-checked and verified

Key Differentiators

Strong Challenger

Pathos AI is an established challenger with significant market presence and competitive offerings in Healthcare & Life Sciences.

Frequently Asked Questions

Estimated Visibility Trend (Beta)

Simulated 8-week rolling score

52
→ Stable

Based on estimated brand signals. Historical tracking coming soon.

Similar Brands

Pfizer logo

Pfizer

Healthcare Tech
B2bHealthtechManufacturingSaasPublic

Pfizer is one of the world's largest biopharmaceutical companies, founded in 1849 by cousins Charles Pfizer and Charles Erhart in Brooklyn, New York, and now headquartered in New York City. The compan

Moderna logo

Moderna

Healthcare Tech
B2bHealthtechManufacturingSaasPublic

Moderna is a clinical-stage biotechnology company that pioneered the development of messenger RNA (mRNA) therapeutics and vaccines, founded in 2010 by Noubar Afeyan, Robert Langer, Kenneth Chien, Stép

Amgen logo

Amgen

Healthcare Tech
B2bHealthtechManufacturingSaasPublic

Amgen Inc. is one of the world's largest biotechnology companies, headquartered in Thousand Oaks, California. Founded in 1980 as Applied Molecular Genetics, Amgen pioneered the development of biologic

Veeva Systems logo

Veeva Systems

Healthcare Tech
B2bHealthtechSaasPublic

Veeva Systems Inc. is the leading cloud software provider for the global life sciences industry, headquartered in Pleasanton, California. Founded in 2007 by Peter Gassner (a former Salesforce executiv

Zocdoc logo

Zocdoc

HealthTech
AnalyticsB2bB2cHealthtechMarketplaceMobile FirstPlatformSaas

Zocdoc operates a two-sided marketplace connecting patients with physicians, dentists, and mental health providers who accept their specific insurance and have real-time appointment availability. Pati

Doximity logo

Doximity

HealthTech
HealthtechSaasB2bB2cStartupPlatformAi PoweredMobile First

Doximity is a professional network and digital health platform purpose-built for licensed physicians and other healthcare professionals in the United States. With more than two million verified clinic

Compare Pathos AI with Competitors

Side-by-side AI visibility scores, platform breakdown, and market position.

For Pathos AI

Claim This Profile

Are you from Pathos AI? Verify your company email to claim this profile and keep its description, products, and FAQs up to date.

Claim Pathos AI Profile →
For competitors & analysts

Track AI Visibility in Real Time

Monitor how ChatGPT, Gemini, Perplexity, and Claude mention Pathos AI vs competitors. Get alerts when AI recommendations shift.

Start Free Tracking →